Bellevue Group AG
Q3 2023 13F-HR Holdings
Net value change ($000)
-803,527
(-11.5%)
New positions
11
Sold out positions
13
Turnover %
0.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ARGX | 88,304 | 24.5% |
| NBIX | 44,262 | 18.0% |
| IONS | 33,967 | 8.8% |
| ELV | 30,195 | 66.3% |
| UNH | 29,189 | 28.9% |
| HUM | 25,779 | 45.3% |
| CI | 21,760 | 153.9% |
| Axonics, Inc. | 14,214 | 12.7% |
| CNC | 10,855 | 55.0% |
| INSM | 10,210 | 14.7% |
Top Reduces (Value $000, Stocks/ETFs)
| INSP | -101,939 | -88.0% |
| Sage Therapeutics, Inc. | -74,133 | -50.6% |
| MDT | -73,997 | -59.5% |
| PODD | -51,142 | -54.8% |
| ISRG | -45,682 | -15.9% |
| OM | -42,159 | -61.7% |
| PACB | -39,823 | -39.7% |
| Intra-Cellular Therapies, Inc. | -37,600 | -18.5% |
| VRTX | -37,413 | -9.7% |
| DXCM | -33,909 | -34.6% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|